Army ‘Leans In’ To Protect A Shooter’s Brain From Blast Injury
(By Jon Hamilton for NPR) For the first time, the U.S. military is speaking publicly about what it’s doing to
Read More(By Jon Hamilton for NPR) For the first time, the U.S. military is speaking publicly about what it’s doing to
Read MoreThere are no easy answers when it comes to preventing deadly blood clots in people in the elevated risk category.
Read More(By Erin Mershon for ST A T) Johnson & Johnson’s Actelion Pharmaceuticals, Celgene, and Gilead Life Sciences are all potentially
Read More(By Alison Kodjak for NPR) When Celgene Corp. first started marketing the drug Revlimid to treat multiple myeloma in 2006,
Read MoreIn 2017, the Food and Drug Administration approved the first chimeric antigen receptor (CAR)-T cell therapies, now the Centers for
Read More(By Megan Knowles for Becker’s Hospital Review ) CMS seeks to combine various Medicare quality improvement programs under a single
Read More(By Julie Spitzer for Becker’s Hospital Review ) Despite a HIPAA-granted right to their own medical records, patients still struggle
Read More(By Lev Facher for ST A T) WASHINGTON — The Food and Drug Administration on Wednesday approved for the first
Read MoreWhen the President signed the Bipartisan Budget Act of 2018 on February 9 th , this legislation affected those individuals
Read More(By Richard Harris for NPR) Sometimes less may be better when it comes to treatment for breast cancer. A new
Read More